{"gene":"HESX1","run_date":"2026-06-10T01:55:22","timeline":{"discoveries":[{"year":1998,"finding":"A homozygous Arg53Cys missense mutation within the HESX1 homeodomain destroyed its ability to bind target DNA, establishing that DNA binding by HESX1 is required for normal forebrain, midline, and pituitary development. Mouse knockouts lacking Hesx1 showed variable anterior CNS defects and pituitary dysplasia.","method":"Gel shift (EMSA) DNA-binding assay of mutant protein; targeted gene knockout in mice with phenotypic analysis","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — in vitro DNA-binding assay directly demonstrating loss of function, combined with knockout mouse phenotype; replicated across human and mouse","pmids":["9620767"],"is_preprint":false},{"year":1995,"finding":"Hesx1 (Rpx) is expressed as two transcripts encoding an identical 185-amino-acid homeodomain protein that defines a new homeodomain class (sharing 80% identity with Xenopus XANF-1). Expression is down-regulated during ES cell differentiation, consistent with a role in early developmental decisions.","method":"Molecular cloning, sequencing, Northern blot, and tissue-specific expression analysis from embryonic stem cells","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — biochemical characterization of a novel gene with sequence analysis and expression profiling; single lab, multiple methods","pmids":["7876132"],"is_preprint":false},{"year":1996,"finding":"In the Ames dwarf (df) mouse, the df gene acts upstream of Pit1 in pituitary ontogeny: df mutants fail to extinguish Rpx/Hesx1 transcription by e13.5, and the pituitary is hypocellular, whereas Pit1-mutant pituitaries down-regulate Rpx normally. This genetic epistasis places Rpx repression as a prerequisite for lineage-specific cell proliferation.","method":"Genetic epistasis analysis in double-mutant mice (df and Pit1-dw); RNA in situ hybridization; pituitary cell-size measurements","journal":"Molecular endocrinology (Baltimore, Md.)","confidence":"High","confidence_rationale":"Tier 2 / Strong — rigorous double-mutant epistasis with multiple orthogonal readouts (gene expression, cell proliferation), clearly ordering gene function","pmids":["8961267"],"is_preprint":false},{"year":2000,"finding":"Hesx1 is required cell-autonomously within the anterior neural ectoderm (ANE) for normal forebrain formation. Chimeric analysis showed that Hesx1-deficient visceral endoderm does not cause forebrain defects, but Hesx1-null cells in the ANE do. Downstream ANE markers Six3 and Rax/Rx are normally expressed until the early somite stage but become markedly reduced ~24 h after Hesx1 is first expressed in the ANE.","method":"Chimeric embryo analysis (ES cell injection into wild-type blastocysts and reciprocal); RNA in situ hybridization for tissue markers","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal chimeric rescue experiments combined with marker in situ hybridization, rigorously establishing cell-autonomous ANE requirement","pmids":["10882526"],"is_preprint":false},{"year":2001,"finding":"HESX1 is a promoter-specific transcriptional repressor with a minimal 36-amino-acid repression domain. It suppresses homeodomain-containing activator proteins. Wild-type HESX1 binds a dimeric homeodomain site with high affinity (Kd ~31 nM); HESX1-S170L binds with ~5-fold lower affinity (Kd ~150 nM); HESX1-R160C does not bind DNA at all. HESX1-R160C also acts as a dominant negative by inhibiting wild-type HESX1 DNA binding both in vitro and in cell culture, via its repression domain.","method":"Electrophoretic mobility shift assay (EMSA) with purified proteins; luciferase reporter transcription assays in cell culture; deletion mutagenesis defining the repression domain","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 1 / Strong — quantitative in vitro binding assays with mutagenesis, complemented by cell-based reporter assays; multiple orthogonal methods in a single rigorous study","pmids":["11748154"],"is_preprint":false},{"year":2001,"finding":"Gel shift analysis of the HESX1-S170L mutant protein showed a significant reduction in relative DNA-binding activity, linking this heterozygous mutation to sporadic pituitary hypoplasia.","method":"Gel shift (EMSA) assay of mutant HESX1 protein","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — direct in vitro DNA-binding assay, but single method in a single lab","pmids":["11136712"],"is_preprint":false},{"year":2003,"finding":"A homozygous I26T mutation in the Engrailed homology 1 (eh1) repressor domain of HESX1 does not affect DNA binding but abolishes recruitment of the Groucho homologue/TLE1 corepressor, leading to partial loss of transcriptional repression. This demonstrates that the eh1 domain is required for HESX1–TLE1 interaction and full repressor activity.","method":"In vitro binding assays (co-immunoprecipitation of HESX1 and TLE1); transcriptional repression assays in cell culture with wild-type and I26T mutant HESX1; EMSA for DNA binding","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — multiple orthogonal methods (CoIP, reporter assay, EMSA) in a single study dissecting distinct functional domains; single lab","pmids":["14561704"],"is_preprint":false},{"year":2003,"finding":"A novel HESX1 mutation (g.1684delG) generates a mutant protein with increased DNA-binding activity, causing enhanced repression of PROP1-dependent gene activity. This demonstrates that gain-of-repressor function is a mechanism for congenital pituitary disorders, distinct from previously described loss-of-function mutations.","method":"Luciferase reporter transcriptional repression assays; EMSA DNA-binding assays with mutant HESX1 protein","journal":"The Journal of clinical endocrinology and metabolism","confidence":"Medium","confidence_rationale":"Tier 1–2 / Moderate — reporter and EMSA assays demonstrating gain-of-function; single lab with two orthogonal methods","pmids":["14557462"],"is_preprint":false},{"year":2006,"finding":"Two novel homozygous HESX1 mutations (a frameshift c.449_450delAC and a splice defect c.357+2T>C) produce truncated proteins lacking part or all of the homeodomain, with complete loss of transcriptional repressor activity as demonstrated by inability to inhibit PROP1 activity in reporter assays.","method":"Sequencing of HESX1 exons; RT-PCR analysis of transcripts from splice mutant; luciferase-based transcriptional repression assay","journal":"The Journal of clinical endocrinology and metabolism","confidence":"Medium","confidence_rationale":"Tier 1–2 / Moderate — functional reporter assay combined with transcript analysis; single lab","pmids":["16940453"],"is_preprint":false},{"year":2007,"finding":"Hesx1 functions as an essential repressor in the anterior forebrain; its absence leads to a posterior transformation of the anterior forebrain via ectopic activation of Wnt/β-catenin signalling within the Hesx1 expression domain. Conditional deletion of β-catenin in the anterior forebrain of Hesx1-deficient embryos significantly rescues the forebrain defects.","method":"Genetic cell labelling; marker gene analysis; conditional knockout of β-catenin in Hesx1-null background (double mutant rescue); transcriptional profiling of anterior forebrain precursors","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional double-mutant rescue with multiple orthogonal methods; pathway placement via genetic epistasis","pmids":["17360769"],"is_preprint":false},{"year":2007,"finding":"DNMT1 (DNA methyltransferase 1) is a binding partner of HESX1. The entire HESX1 protein is required for binding to the N-terminus and catalytic C-terminal domain of DNMT1. HESX1–DNMT1 complexes co-immunoprecipitate in cells and co-localise in the nucleus; Dnmt1 and Hesx1 are co-expressed in anterior forebrain and Rathke's pouch.","method":"Yeast two-hybrid screen; co-immunoprecipitation; deletion-mutant binding mapping; co-localisation by immunofluorescence in cells","journal":"Biochimica et biophysica acta","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — yeast two-hybrid plus reciprocal co-IP plus co-localisation; single lab","pmids":["17931718"],"is_preprint":false},{"year":2008,"finding":"Knock-in mice carrying the I26T substitution in Hesx1 show pituitary defects comparable to Hesx1-null mice, confirming I26T as a hypomorphic allele. Knock-in mice carrying R160C show full forebrain and pituitary defects identical to null mice, confirming R160C is a null allele. HESX1 expression during early human development mirrors the mouse, supporting conservation of function.","method":"Generation of two Hesx1 knock-in mouse lines (I26T and R160C) by gene targeting; histological and molecular phenotypic analysis; immunohistochemistry in human embryos","journal":"Disease models & mechanisms","confidence":"High","confidence_rationale":"Tier 2 / Strong — two independent knock-in models with rigorous phenotypic characterisation establish allelic series","pmids":["19093031"],"is_preprint":false},{"year":2008,"finding":"Hesx1 interacts genetically with Six3 during pituitary development: Six3+/-;Hesx1Cre/+ compound heterozygous mice display severe pituitary hypoplasia with an expanded/bifurcated Rathke's pouch due to increased cell proliferation, revealing a genetic interaction between Hesx1 and Six3 in controlling pituitary organogenesis.","method":"Generation of Six3+/-;Hesx1Cre/+ double-heterozygous mice; histological and proliferation analyses; endocrine phenotype assessment","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — clean genetic epistasis in vivo with multiple tissue readouts; single lab","pmids":["18775421"],"is_preprint":false},{"year":2008,"finding":"The Xenopus/Hesx1 ortholog Xanf1 binds the LIM-domain protein Zyxin through its Engrailed-type repressor domain (eh1), and Zyxin LIM2 domain is required for the interaction. Zyxin overexpression mimics Xanf1 knockdown, while a repressor-fused Zyxin mimics Xanf1 overexpression, indicating Zyxin acts as a negative modulator of Xanf1 transcriptional repressing activity in the anterior neural plate.","method":"Deletion-mutant pulldown mapping; Xenopus embryo overexpression and morpholino knockdown with phenotypic readout","journal":"Developmental dynamics","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — binding domain mapping combined with in vivo gain/loss-of-function; single lab","pmids":["18297730"],"is_preprint":false},{"year":2010,"finding":"HESX1 interacts with both TLE1 and TLE3 corepressors to repress PROP1-dependent transcription. TLE3 had not previously been shown to interact with HESX1. In transgenic mice, HESX1 alone (but not TLE3 alone) suppresses terminal differentiation of thyrotrophs and gonadotrophs when constitutively expressed, and TLE3 together with HESX1 shows similar suppression, demonstrating that TLE corepressors augment HESX1-mediated repression.","method":"Cell-based luciferase reporter assays; co-immunoprecipitation; transgenic mouse overexpression in pituitary thyrotrophs/gonadotrophs with cell differentiation readout","journal":"Molecular endocrinology (Baltimore, Md.)","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal CoIP, reporter assays, and transgenic in vivo validation; multiple orthogonal methods","pmids":["20181723"],"is_preprint":false},{"year":2011,"finding":"HESX1 and TCF3 (a transcriptional repressor of Wnt target genes) act synergistically to maintain anterior forebrain identity by repressing Wnt/β-catenin targets. Hesx1/Tcf3 double-heterozygous mice show severe forebrain defects not seen in single heterozygotes. Morpholino knockdown of hesx1 in tcf3-mutant zebrafish causes severe forebrain and eye defects. Tcf3 conditional knockout in the neural ectoderm causes anterior forebrain loss, and Tcf3/Hesx1 compound deficiency amplifies this. Transcriptional profiling of Hesx1-expressing forebrain precursors provides molecular evidence for Wnt target repression.","method":"Double-mutant mouse epistasis; zebrafish morpholino knockdown in sensitised tcf3 mutant background; conditional knockout; transcriptional profiling (gene expression array)","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple species (mouse, zebrafish), conditional and compound knockouts, transcriptional profiling; independently convergent methods","pmids":["22007134"],"is_preprint":false},{"year":2004,"finding":"The HESX1/ANF homeobox gene promoter is directly activated by Otx2 through two conserved Otx2-binding sites in a ~1-kb upstream enhancer, as shown by in vivo mutagenesis in chick and zebrafish transgenic embryos. Additionally, Pax6 occupies a binding site near the transcriptional start site in vivo and inhibits GANF/Hesx1 expression: Pax6 overexpression represses endogenous GANF, and in Pax6-null mice the Hesx1 expression domain is expanded and prolonged.","method":"In vivo site mutagenesis in transgenic chick and zebrafish; chromatin/in vivo occupancy analysis; Pax6-null mouse marker analysis; overexpression experiments","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo mutagenesis plus loss-of-function in Pax6 knockout; single lab with multiple complementary approaches","pmids":["15110720"],"is_preprint":false},{"year":2006,"finding":"Conserved 5′ upstream regulatory sequences of Rpx/Hesx1 contain two LIM protein-binding sites that are required for Rpx promoter activity and are directly bound by LIM homeodomain proteins Lhx1 and Lhx3, which regulate early Rpx transcription in the anterior endoderm and neural plate. A conserved 3′ enhancer is necessary and sufficient for Rpx expression in Rathke's pouch.","method":"Transgenic mouse reporter analysis with deletion constructs; electrophoretic mobility shift assay (EMSA) for Lhx1 and Lhx3 binding; Xenopus transgenic assay","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 1–2 / Moderate — EMSA plus in vivo transgenic reporter mutagenesis; single lab with two species","pmids":["16527264"],"is_preprint":false},{"year":2008,"finding":"Wild-type OTX2 protein binds to the HESX1 promoter and transactivates it ~4.5-fold. A frameshift OTX2 mutation that retains the homeodomain but loses the transactivation domain fails to transactivate the HESX1 promoter, establishing HESX1 as a direct transcriptional target of OTX2 in the pituitary context.","method":"Luciferase reporter assay with wild-type and mutant OTX2; nuclear localisation confirmed by imaging","journal":"The Journal of clinical endocrinology and metabolism","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — reporter assay is direct, but single lab, single method for the HESX1 promoter specifically","pmids":["18628516"],"is_preprint":false},{"year":2016,"finding":"Compound heterozygous HESX1 mutations p.R159W and p.R160H each abrogate the ability of HESX1 to repress PROP1-mediated transcriptional activation, demonstrating that both residues are required for HESX1 repressor function toward PROP1.","method":"Luciferase reporter transcriptional repression assay with mutant HESX1 proteins","journal":"Clinical endocrinology","confidence":"Medium","confidence_rationale":"Tier 1–2 / Weak — direct functional reporter assay, single lab, single method","pmids":["27000987"],"is_preprint":false}],"current_model":"HESX1 is a homeodomain transcriptional repressor that is expressed sequentially in the anterior visceral endoderm, anterior axial mesendoderm, and anterior neural ectoderm during early development, where it is required cell-autonomously for forebrain patterning by repressing Wnt/β-catenin target genes (in concert with TCF3) and for Rathke's pouch morphogenesis; it represses target promoters through a 36-amino-acid Engrailed-homology (eh1) domain that recruits the Groucho-related corepressors TLE1 and TLE3, and through its homeodomain that binds dimeric homeodomain sites with high affinity to antagonize PROP1-mediated activation; its transcription is activated by Otx2 and LIM-homeodomain proteins (Lhx1, Lhx3) and repressed by Pax6, while it can also interact with DNMT1 and Zyxin, broadening the repertoire of mechanisms through which it enforces anterior neural identity."},"narrative":{"mechanistic_narrative":"HESX1 is a homeodomain transcriptional repressor that enforces anterior neural identity and pituitary organogenesis during early development, where it is required cell-autonomously within the anterior neural ectoderm for forebrain formation [PMID:10882526, PMID:17360769]. It binds dimeric homeodomain DNA sites with high affinity through its homeodomain, and mutations that abolish or weaken this binding (R160C, S170L) cause forebrain, midline, and pituitary defects; R160C additionally acts as a dominant negative by sequestering wild-type protein [PMID:9620767, PMID:11748154, PMID:11136712, PMID:19093031]. Repression is executed through a 36-amino-acid Engrailed-homology (eh1) domain that recruits the Groucho-related corepressors TLE1 and TLE3, and an eh1 point mutation (I26T) abolishes TLE1 recruitment and produces a hypomorphic allele in vivo [PMID:14561704, PMID:19093031, PMID:20181723]. In the forebrain, HESX1 antagonizes Wnt/β-catenin signalling to prevent posterior transformation of anterior tissue, acting synergistically with the Wnt repressor TCF3, and conditional removal of β-catenin rescues the Hesx1-null forebrain [PMID:17360769, PMID:22007134]. In the pituitary it antagonizes PROP1-mediated activation, and its own expression must be extinguished to permit lineage-specific proliferation, as shown by genetic epistasis with the Ames dwarf locus and Six3 [PMID:8961267, PMID:18775421, PMID:27000987]. HESX1 transcription is directly activated by OTX2 and by the LIM-homeodomain proteins Lhx1 and Lhx3, and repressed by Pax6 [PMID:15110720, PMID:16527264, PMID:18628516]. It also physically interacts with DNMT1 and, via its ortholog Xanf1, with Zyxin, extending the repertoire of its repressive mechanisms [PMID:17931718, PMID:18297730].","teleology":[{"year":1995,"claim":"Established HESX1/Rpx as a novel-class homeodomain protein whose expression marks early developmental decisions, defining the molecule before its function was known.","evidence":"Molecular cloning, sequencing, and expression profiling in differentiating ES cells","pmids":["7876132"],"confidence":"Medium","gaps":["No functional or phenotypic data","DNA-binding specificity not yet defined"]},{"year":1996,"claim":"Placed Rpx/Hesx1 repression upstream of Pit1 in pituitary ontogeny, showing that its extinction is a prerequisite for lineage-specific proliferation.","evidence":"Double-mutant epistasis (Ames df and Pit1-dw mice) with in situ hybridization and cell-size measurement","pmids":["8961267"],"confidence":"High","gaps":["Molecular identity of the df gene unresolved here","Direct transcriptional targets not identified"]},{"year":1998,"claim":"Demonstrated that DNA binding by HESX1 is required for forebrain, midline, and pituitary development by linking a homeodomain missense mutation that abolishes binding to disease and recapitulating defects in knockout mice.","evidence":"EMSA of mutant protein plus targeted knockout in mice with phenotypic analysis","pmids":["9620767"],"confidence":"High","gaps":["Target genes bound in vivo not defined","Repression mechanism not yet established"]},{"year":2000,"claim":"Resolved the tissue of action, showing HESX1 is required cell-autonomously in the anterior neural ectoderm rather than visceral endoderm for forebrain formation.","evidence":"Reciprocal chimeric embryo analysis with marker in situ hybridization (Six3, Rax)","pmids":["10882526"],"confidence":"High","gaps":["Direct vs indirect regulation of Six3/Rax not distinguished","Signalling pathway antagonized not identified"]},{"year":2001,"claim":"Defined HESX1 as a promoter-specific repressor with a minimal 36-residue repression domain and quantified how disease mutations alter DNA binding, including a dominant-negative mechanism.","evidence":"Quantitative EMSA with purified proteins, luciferase reporter assays, deletion mutagenesis (with allele-specific EMSA in a parallel study)","pmids":["11748154","11136712"],"confidence":"High","gaps":["Corepressor recruited by the repression domain not yet identified","Physiological target promoters unknown"]},{"year":2003,"claim":"Identified the eh1 domain as the corepressor-recruitment module by showing an I26T mutation preserves DNA binding but abolishes TLE1/Groucho recruitment, and documented a gain-of-repressor mechanism for pituitary disease.","evidence":"Co-IP of HESX1 and TLE1, reporter repression assays, and EMSA; separate reporter/EMSA study of a frameshift gain-of-function allele","pmids":["14561704","14557462"],"confidence":"High","gaps":["Whether TLE recruitment occurs at endogenous promoters not shown","In vivo consequence of I26T not yet tested at this stage"]},{"year":2004,"claim":"Connected HESX1 to its upstream regulatory network by showing Otx2 directly activates and Pax6 directly represses the promoter.","evidence":"In vivo site mutagenesis in transgenic chick/zebrafish, occupancy analysis, and Pax6-null marker analysis","pmids":["15110720"],"confidence":"Medium","gaps":["Combinatorial logic of activators and repressors not resolved","Single lab"]},{"year":2006,"claim":"Extended the upstream network by mapping distinct enhancers and showing LIM-homeodomain proteins Lhx1 and Lhx3 directly bind and drive early Rpx transcription.","evidence":"Transgenic reporter deletion analysis and EMSA in mouse and Xenopus","pmids":["16527264"],"confidence":"Medium","gaps":["Functional requirement of Lhx binding in vivo not tested by knockout","3' Rathke's pouch enhancer regulators not identified"]},{"year":2007,"claim":"Established the core developmental mechanism: HESX1 represses Wnt/β-catenin signalling to prevent posterior transformation of anterior forebrain, and identified DNMT1 as a physical partner.","evidence":"Conditional β-catenin deletion in Hesx1-null background (rescue) with profiling; yeast two-hybrid, co-IP, and co-localization for DNMT1","pmids":["17360769","17931718"],"confidence":"High","gaps":["Direct Wnt target promoters bound by HESX1 not enumerated","Functional consequence of DNMT1 interaction not demonstrated"]},{"year":2008,"claim":"Validated the allelic series in vivo (I26T hypomorph, R160C null), revealed genetic interaction with Six3 in pituitary proliferation, identified Zyxin as a negative modulator of the ortholog, and confirmed OTX2 directly transactivates the HESX1 promoter.","evidence":"Two knock-in mouse lines; Six3;Hesx1 compound heterozygote analysis; Xenopus Xanf1–Zyxin pulldown and gain/loss-of-function; OTX2 reporter assay","pmids":["19093031","18775421","18297730","18628516"],"confidence":"High","gaps":["Mechanism by which Six3 dosage controls pouch proliferation unresolved","Zyxin modulation shown only in Xenopus ortholog"]},{"year":2010,"claim":"Broadened the corepressor mechanism by showing HESX1 recruits both TLE1 and TLE3 to repress PROP1-dependent transcription, with TLE corepressors augmenting repression in vivo.","evidence":"Reciprocal co-IP, reporter assays, and transgenic pituitary overexpression with differentiation readout","pmids":["20181723"],"confidence":"High","gaps":["Endogenous PROP1 target genes co-repressed not mapped","Relative contribution of TLE1 vs TLE3 in vivo unclear"]},{"year":2011,"claim":"Demonstrated that HESX1 and TCF3 act synergistically to repress Wnt targets and maintain anterior forebrain identity across species.","evidence":"Double-mutant mouse epistasis, zebrafish morpholino knockdown in tcf3 background, conditional knockout, and transcriptional profiling","pmids":["22007134"],"confidence":"High","gaps":["Whether HESX1 and TCF3 co-occupy shared promoters not shown directly","Specific Wnt target genes repressed not fully enumerated"]},{"year":2016,"claim":"Confirmed that conserved homeodomain residues R159 and R160 are individually required for repression of PROP1, refining genotype-phenotype relationships.","evidence":"Luciferase reporter repression assay with compound-heterozygous mutant proteins","pmids":["27000987"],"confidence":"Medium","gaps":["DNA-binding consequences of these residues not assayed here","Single method, single lab"]},{"year":null,"claim":"The genome-wide direct target repertoire of HESX1 and how its DNMT1 interaction contributes to repression at endogenous loci remain undefined.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No ChIP-based genome-wide occupancy map","Functional role of HESX1–DNMT1 in DNA methylation untested","Structural model of the homeodomain on dimeric sites lacking"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0,4,5,7]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[4,6,14,15]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[6,14]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[10]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[4,6,14]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[3,9,12,15]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[9,15]}],"complexes":[],"partners":["TLE1","TLE3","PROP1","TCF3","DNMT1","OTX2","LHX1","LHX3"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9UBX0","full_name":"Homeobox expressed in ES cells 1","aliases":["Homeobox protein ANF","hAnf"],"length_aa":185,"mass_kda":21.4,"function":"Required for the normal development of the forebrain, eyes and other anterior structures such as the olfactory placodes and pituitary gland. Possible transcriptional repressor. Binds to the palindromic PIII sequence, 5'-AGCTTGAGTCTAATTGAATTAACTGTAC-3'. HESX1 and PROP1 bind as heterodimers on this palindromic site, and, in vitro, HESX1 can antagonize PROP1 activation","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q9UBX0/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/HESX1","classification":"Not Classified","n_dependent_lines":16,"n_total_lines":1208,"dependency_fraction":0.013245033112582781},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/HESX1","total_profiled":1310},"omim":[{"mim_id":"613986","title":"PITUITARY HORMONE DEFICIENCY, COMBINED, 6; CPHD6","url":"https://www.omim.org/entry/613986"},{"mim_id":"613038","title":"PITUITARY HORMONE DEFICIENCY, COMBINED OR ISOLATED, 1; CPHD1","url":"https://www.omim.org/entry/613038"},{"mim_id":"610125","title":"MICROPHTHALMIA, SYNDROMIC 5; MCOPS5","url":"https://www.omim.org/entry/610125"},{"mim_id":"601802","title":"HESX HOMEOBOX 1; HESX1","url":"https://www.omim.org/entry/601802"},{"mim_id":"600037","title":"ORTHODENTICLE HOMEOBOX 2; OTX2","url":"https://www.omim.org/entry/600037"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in many","driving_tissues":[],"url":"https://www.proteinatlas.org/search/HESX1"},"hgnc":{"alias_symbol":["RPX","ANF"],"prev_symbol":[]},"alphafold":{"accession":"Q9UBX0","domains":[{"cath_id":"1.10.10.60","chopping":"115-185","consensus_level":"medium","plddt":89.5668,"start":115,"end":185}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UBX0","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UBX0-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UBX0-F1-predicted_aligned_error_v6.png","plddt_mean":71.81},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=HESX1","jax_strain_url":"https://www.jax.org/strain/search?query=HESX1"},"sequence":{"accession":"Q9UBX0","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9UBX0.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9UBX0/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UBX0"}},"corpus_meta":[{"pmid":"9620767","id":"PMC_9620767","title":"Mutations in the homeobox gene HESX1/Hesx1 associated with septo-optic dysplasia in human and mouse.","date":"1998","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9620767","citation_count":513,"is_preprint":false},{"pmid":"12023302","id":"PMC_12023302","title":"Cooperative action of Tbx2 and Nkx2.5 inhibits ANF expression in the atrioventricular canal: implications for cardiac chamber formation.","date":"2002","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/12023302","citation_count":292,"is_preprint":false},{"pmid":"8565852","id":"PMC_8565852","title":"Rpx: a novel anterior-restricted homeobox gene progressively activated in the prechordal plate, anterior neural plate and Rathke's pouch of the mouse embryo.","date":"1996","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/8565852","citation_count":245,"is_preprint":false},{"pmid":"11136712","id":"PMC_11136712","title":"Heterozygous HESX1 mutations associated with isolated congenital pituitary hypoplasia and septo-optic dysplasia.","date":"2001","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11136712","citation_count":208,"is_preprint":false},{"pmid":"2430471","id":"PMC_2430471","title":"Myocardial recruitment during ANF mRNA increase with volume overload in the rat.","date":"1986","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/2430471","citation_count":204,"is_preprint":false},{"pmid":"8961267","id":"PMC_8961267","title":"The Ames dwarf gene, df, is required early in pituitary ontogeny for the extinction of Rpx transcription and initiation of lineage-specific cell proliferation.","date":"1996","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/8961267","citation_count":138,"is_preprint":false},{"pmid":"11748154","id":"PMC_11748154","title":"Molecular effects of novel mutations in Hesx1/HESX1 associated with human pituitary disorders.","date":"2001","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/11748154","citation_count":104,"is_preprint":false},{"pmid":"17148560","id":"PMC_17148560","title":"HESX1 mutations are an uncommon cause of septooptic dysplasia and hypopituitarism.","date":"2006","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/17148560","citation_count":104,"is_preprint":false},{"pmid":"14561704","id":"PMC_14561704","title":"A homozygous mutation in HESX1 is associated with evolving hypopituitarism due to impaired repressor-corepressor interaction.","date":"2003","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/14561704","citation_count":103,"is_preprint":false},{"pmid":"16199874","id":"PMC_16199874","title":"Hey basic helix-loop-helix transcription factors are repressors of GATA4 and GATA6 and restrict expression of the GATA target gene ANF in fetal hearts.","date":"2005","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16199874","citation_count":98,"is_preprint":false},{"pmid":"7876132","id":"PMC_7876132","title":"Sequence, genomic organization, and expression of the novel homeobox gene Hesx1.","date":"1995","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7876132","citation_count":93,"is_preprint":false},{"pmid":"10882526","id":"PMC_10882526","title":"The homeobox gene Hesx1 is required in the anterior neural ectoderm for normal forebrain formation.","date":"2000","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/10882526","citation_count":91,"is_preprint":false},{"pmid":"12519827","id":"PMC_12519827","title":"Sporadic heterozygous frameshift mutation of HESX1 causing pituitary and optic nerve hypoplasia and combined pituitary hormone deficiency in a Japanese patient.","date":"2003","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/12519827","citation_count":88,"is_preprint":false},{"pmid":"9486247","id":"PMC_9486247","title":"ANF elicits phosphorylation of the cGMP phosphodiesterase in vascular smooth muscle cells.","date":"1998","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/9486247","citation_count":85,"is_preprint":false},{"pmid":"7657806","id":"PMC_7657806","title":"Divergent pathways mediate the induction of ANF transgenes in neonatal and hypertrophic ventricular myocardium.","date":"1995","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/7657806","citation_count":84,"is_preprint":false},{"pmid":"12941624","id":"PMC_12941624","title":"Transgenic analysis of the atrialnatriuretic factor (ANF) promoter: Nkx2-5 and GATA-4 binding sites are required for atrial specific expression of ANF.","date":"2003","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/12941624","citation_count":79,"is_preprint":false},{"pmid":"1394917","id":"PMC_1394917","title":"Neurohormonal inhibition and hemodynamic unloading during prolonged inhibition of ANF degradation in patients with severe chronic heart failure.","date":"1992","source":"Circulation","url":"https://pubmed.ncbi.nlm.nih.gov/1394917","citation_count":79,"is_preprint":false},{"pmid":"2871836","id":"PMC_2871836","title":"Mechanisms of release of atrial natriuretic factor. II. Effect of chronic administration of alpha- and beta-adrenergic and cholinergic agonists on plasma and atrial ANF in the rat.","date":"1986","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/2871836","citation_count":78,"is_preprint":false},{"pmid":"2529858","id":"PMC_2529858","title":"UK-69,578, a novel inhibitor of EC 3.4.24.11 which increases endogenous ANF levels and is natriuretic and diuretic.","date":"1989","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/2529858","citation_count":78,"is_preprint":false},{"pmid":"4038600","id":"PMC_4038600","title":"Structure-activity relationships of atrial natriuretic factor (ANF). II. Effect of chain-length modifications on vascular reactivity.","date":"1985","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/4038600","citation_count":78,"is_preprint":false},{"pmid":"17360769","id":"PMC_17360769","title":"Lack of the murine homeobox gene Hesx1 leads to a posterior transformation of the anterior forebrain.","date":"2007","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/17360769","citation_count":68,"is_preprint":false},{"pmid":"7805853","id":"PMC_7805853","title":"Classical, novel and atypical isoforms of PKC stimulate ANF- and TRE/AP-1-regulated-promoter activity in ventricular cardiomyocytes.","date":"1994","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/7805853","citation_count":68,"is_preprint":false},{"pmid":"1847022","id":"PMC_1847022","title":"Influence of C-ANF receptor and neutral endopeptidase on pharmacokinetics of ANF in rats.","date":"1991","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/1847022","citation_count":66,"is_preprint":false},{"pmid":"3034249","id":"PMC_3034249","title":"Divergence of ANF analogs in smooth muscle cell cGMP response and aorta vasorelaxation: evidence for receptor subtypes.","date":"1987","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/3034249","citation_count":66,"is_preprint":false},{"pmid":"15670191","id":"PMC_15670191","title":"Mutation analysis of POUF-1, PROP-1 and HESX-1 show low frequency of mutations in children with sporadic forms of combined pituitary hormone deficiency and septo-optic dysplasia.","date":"2005","source":"Clinical endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/15670191","citation_count":63,"is_preprint":false},{"pmid":"1825155","id":"PMC_1825155","title":"Kidney function in ANF-transgenic mice: effect of blood volume expansion.","date":"1991","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/1825155","citation_count":62,"is_preprint":false},{"pmid":"14557462","id":"PMC_14557462","title":"Enhanced repression by HESX1 as a cause of hypopituitarism and septooptic dysplasia.","date":"2003","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/14557462","citation_count":61,"is_preprint":false},{"pmid":"2827518","id":"PMC_2827518","title":"Glomerular ANF receptor regulation during changes in sodium and water metabolism.","date":"1988","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/2827518","citation_count":59,"is_preprint":false},{"pmid":"18628516","id":"PMC_18628516","title":"OTX2 mutation in a patient with anophthalmia, short stature, and partial growth hormone deficiency: functional studies using the IRBP, HESX1, and POU1F1 promoters.","date":"2008","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/18628516","citation_count":58,"is_preprint":false},{"pmid":"16940453","id":"PMC_16940453","title":"Novel HESX1 mutations associated with a life-threatening neonatal phenotype, pituitary aplasia, but normally located posterior pituitary and no optic nerve abnormalities.","date":"2006","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/16940453","citation_count":58,"is_preprint":false},{"pmid":"18775421","id":"PMC_18775421","title":"Genetic interaction between the homeobox transcription factors HESX1 and SIX3 is required for normal pituitary development.","date":"2008","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/18775421","citation_count":51,"is_preprint":false},{"pmid":"11558676","id":"PMC_11558676","title":"Regulation of the ANF and BNP promoters by GATA factors: lessons learned for cardiac transcription.","date":"2001","source":"Canadian journal of physiology and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/11558676","citation_count":51,"is_preprint":false},{"pmid":"2173807","id":"PMC_2173807","title":"Degradation and clearance of atrial natriuretic factors (ANF).","date":"1990","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/2173807","citation_count":50,"is_preprint":false},{"pmid":"2570574","id":"PMC_2570574","title":"Urodilatin and beta-ANF: binding properties and activation of particulate guanylate cyclase.","date":"1989","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/2570574","citation_count":50,"is_preprint":false},{"pmid":"10843871","id":"PMC_10843871","title":"The Rho effector, PKN, regulates ANF gene transcription in cardiomyocytes through a serum response element.","date":"2000","source":"American journal of physiology. Heart and circulatory physiology","url":"https://pubmed.ncbi.nlm.nih.gov/10843871","citation_count":49,"is_preprint":false},{"pmid":"2866981","id":"PMC_2866981","title":"ANF stimulation of detergent-dispersed particulate guanylate cyclase from bovine adrenal cortex.","date":"1986","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/2866981","citation_count":49,"is_preprint":false},{"pmid":"772415","id":"PMC_772415","title":"Cooperative control of translational fidelity by ribosomal proteins in Escherichia coli. III. A ram mutation in the structural gene for protein S5 (rpx E).","date":"1976","source":"Molecular & general genetics : MGG","url":"https://pubmed.ncbi.nlm.nih.gov/772415","citation_count":48,"is_preprint":false},{"pmid":"24104878","id":"PMC_24104878","title":"A transgenic mouse model for the simultaneous monitoring of ANF and BNP gene activity during heart development and disease.","date":"2013","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/24104878","citation_count":46,"is_preprint":false},{"pmid":"8745211","id":"PMC_8745211","title":"Influence of fibroblast growth factor (bFGF) and insulin-like growth factor (IGF-I) on cytoskeletal and contractile structures and on atrial natriuretic factor (ANF) expression in adult rat ventricular cardiomyocytes in culture.","date":"1996","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/8745211","citation_count":45,"is_preprint":false},{"pmid":"1721496","id":"PMC_1721496","title":"RT-PCR microlocalization of mRNA for guanylyl cyclase-coupled ANF receptor in rat kidney.","date":"1991","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/1721496","citation_count":43,"is_preprint":false},{"pmid":"15110720","id":"PMC_15110720","title":"Involvement of Pax6 and Otx2 in the forebrain-specific regulation of the vertebrate homeobox gene ANF/Hesx1.","date":"2004","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/15110720","citation_count":42,"is_preprint":false},{"pmid":"22007134","id":"PMC_22007134","title":"HESX1- and TCF3-mediated repression of Wnt/β-catenin targets is required for normal development of the anterior forebrain.","date":"2011","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/22007134","citation_count":42,"is_preprint":false},{"pmid":"2845313","id":"PMC_2845313","title":"ANF receptors: distribution and regulation in central and peripheral tissues.","date":"1988","source":"Neuroscience and biobehavioral reviews","url":"https://pubmed.ncbi.nlm.nih.gov/2845313","citation_count":39,"is_preprint":false},{"pmid":"8304541","id":"PMC_8304541","title":"ANF-C-receptor-mediated inhibition of aortic smooth muscle cell proliferation and thymidine kinase activity.","date":"1994","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/8304541","citation_count":39,"is_preprint":false},{"pmid":"7594419","id":"PMC_7594419","title":"Atrial natriuretic factor modulates nitric oxide production: an ANF-C receptor-mediated effect.","date":"1995","source":"Journal of hypertension","url":"https://pubmed.ncbi.nlm.nih.gov/7594419","citation_count":39,"is_preprint":false},{"pmid":"1313653","id":"PMC_1313653","title":"Captopril enhances renal responsiveness to ANF in dogs with compensated high-output heart failure.","date":"1992","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/1313653","citation_count":39,"is_preprint":false},{"pmid":"8383460","id":"PMC_8383460","title":"Phenylephrine and endothelin differentially stimulate cardiac PI hydrolysis and ANF expression.","date":"1993","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/8383460","citation_count":37,"is_preprint":false},{"pmid":"7547292","id":"PMC_7547292","title":"Heterogeneity within human-derived centers for disease control and prevention (CDC) coryneform group ANF-1-like bacteria and description of Corynebacterium auris sp. nov.","date":"1995","source":"International journal of systematic bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/7547292","citation_count":37,"is_preprint":false},{"pmid":"17201807","id":"PMC_17201807","title":"Hormonal, pituitary magnetic resonance, LHX4 and HESX1 evaluation in patients with hypopituitarism and ectopic posterior pituitary lobe.","date":"2007","source":"Clinical endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/17201807","citation_count":35,"is_preprint":false},{"pmid":"19093031","id":"PMC_19093031","title":"Analysis of mouse models carrying the I26T and R160C substitutions in the transcriptional repressor HESX1 as models for septo-optic dysplasia and hypopituitarism.","date":"2008","source":"Disease models & mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/19093031","citation_count":35,"is_preprint":false},{"pmid":"14646405","id":"PMC_14646405","title":"Clinical characteristics and molecular analysis of PIT1, PROP1,LHX3, and HESX1 in combined pituitary hormone deficiency patients with abnormal pituitary MR imaging.","date":"2003","source":"Hormone research","url":"https://pubmed.ncbi.nlm.nih.gov/14646405","citation_count":34,"is_preprint":false},{"pmid":"8494739","id":"PMC_8494739","title":"Taxonomic study of Corynebacterium Group ANF-1 strains: Proposal of Corynebacterium afermentans sp. nov. containing the subspecies C. afermentans subsp. afermentans subsp. nov. and C. afermentans subsp. lipophilum subsp. nov.","date":"1993","source":"International journal of systematic bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/8494739","citation_count":34,"is_preprint":false},{"pmid":"10673767","id":"PMC_10673767","title":"Dopamine induces a biphasic modulation of hypothalamic ANF neurons: a ligand concentration-dependent effect involving D5 and D2 receptor interaction.","date":"2000","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/10673767","citation_count":33,"is_preprint":false},{"pmid":"8468402","id":"PMC_8468402","title":"Immunocytochemical localization of atrial natriuretic factor (ANF)-like peptides in the brain and heart of the treefrog Hyla japonica: effect of weightlessness on the distribution of immunoreactive neurons and cardiocytes.","date":"1993","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/8468402","citation_count":33,"is_preprint":false},{"pmid":"8301562","id":"PMC_8301562","title":"Losartan improves the natriuretic response to ANF in rats with high-output heart failure.","date":"1994","source":"The Journal of pharmacology and experimental therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/8301562","citation_count":33,"is_preprint":false},{"pmid":"20389107","id":"PMC_20389107","title":"PROP1, HESX1, POU1F1, LHX3 and LHX4 mutation and deletion screening and GH1 P89L and IVS3+1/+2 mutation screening in a Dutch nationwide cohort of patients with combined pituitary hormone deficiency.","date":"2010","source":"Hormone research in paediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/20389107","citation_count":32,"is_preprint":false},{"pmid":"1838021","id":"PMC_1838021","title":"Cellular signals regulating the release of ANF.","date":"1991","source":"Canadian journal of physiology and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/1838021","citation_count":32,"is_preprint":false},{"pmid":"18157385","id":"PMC_18157385","title":"Molecular analysis of PROP1, PIT1, HESX1, LHX3, and LHX4 shows high frequency of PROP1 mutations in patients with familial forms of combined pituitary hormone deficiency.","date":"2007","source":"Arquivos brasileiros de endocrinologia e metabologia","url":"https://pubmed.ncbi.nlm.nih.gov/18157385","citation_count":32,"is_preprint":false},{"pmid":"1473042","id":"PMC_1473042","title":"Role of spleen in ANF-induced reduction in plasma volume.","date":"1992","source":"Canadian journal of physiology and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/1473042","citation_count":32,"is_preprint":false},{"pmid":"7631892","id":"PMC_7631892","title":"Blood pressure and fluid-electrolyte balance in ANF-transgenic mice on high- and low-salt diets.","date":"1995","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/7631892","citation_count":31,"is_preprint":false},{"pmid":"19799869","id":"PMC_19799869","title":"beta-Catenin/TCF/LEF1 can directly regulate phenylephrine-induced cell hypertrophy and Anf transcription in cardiomyocytes.","date":"2009","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/19799869","citation_count":31,"is_preprint":false},{"pmid":"2839333","id":"PMC_2839333","title":"Involvement of Ni protein in the functional coupling of the atrial natriuretic factor (ANF) receptor to adenylate cyclase in rat lung plasma membranes.","date":"1988","source":"European journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/2839333","citation_count":31,"is_preprint":false},{"pmid":"20874724","id":"PMC_20874724","title":"GATA4 regulates ANF expression synergistically with Sp1 in a cardiac hypertrophy model.","date":"2011","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/20874724","citation_count":29,"is_preprint":false},{"pmid":"1443119","id":"PMC_1443119","title":"Pharmacokinetics of ANF and urodilatin during cANF receptor blockade and neutral endopeptidase inhibition.","date":"1992","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/1443119","citation_count":27,"is_preprint":false},{"pmid":"15465036","id":"PMC_15465036","title":"Transforming growth factor-beta induces the expression of ANF and hypertrophic growth in cultured cardiomyoblast cells through ZAK.","date":"2004","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/15465036","citation_count":26,"is_preprint":false},{"pmid":"18297730","id":"PMC_18297730","title":"The LIM-domain protein Zyxin binds the homeodomain factor Xanf1/Hesx1 and modulates its activity in the anterior neural plate of Xenopus laevis embryo.","date":"2008","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/18297730","citation_count":26,"is_preprint":false},{"pmid":"7649305","id":"PMC_7649305","title":"C-type natriuretic peptide and brain natriuretic peptide inhibit adenylyl cyclase activity: interaction with ANF-R2/ANP-C receptors.","date":"1995","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/7649305","citation_count":26,"is_preprint":false},{"pmid":"20181723","id":"PMC_20181723","title":"Corepressors TLE1 and TLE3 interact with HESX1 and PROP1.","date":"2010","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/20181723","citation_count":25,"is_preprint":false},{"pmid":"2964789","id":"PMC_2964789","title":"ANF and exocrine pancreas: ultrastructural autoradiographic localization in acinar cells.","date":"1988","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/2964789","citation_count":25,"is_preprint":false},{"pmid":"2522951","id":"PMC_2522951","title":"Localization of atrial natriuretic factor (ANF) binding sites in the central nervous system of the frog.","date":"1989","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/2522951","citation_count":25,"is_preprint":false},{"pmid":"15895405","id":"PMC_15895405","title":"Comparative analysis of the natriuretic peptide precursor gene cluster in vertebrates reveals loss of ANF and retention of CNP-3 in chicken.","date":"2005","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/15895405","citation_count":24,"is_preprint":false},{"pmid":"2972215","id":"PMC_2972215","title":"ANF inhibits vasopressin-induced Ca2+ mobilization and contraction in glomerular mesangial cells.","date":"1988","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/2972215","citation_count":24,"is_preprint":false},{"pmid":"7643524","id":"PMC_7643524","title":"Effects of urodilatin in the rat kidney: comparison with ANF and interaction with vasoactive substances.","date":"1995","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/7643524","citation_count":24,"is_preprint":false},{"pmid":"18853282","id":"PMC_18853282","title":"A novel SNP of the Hesx1 gene in bovine and its associations with average daily gain.","date":"2008","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/18853282","citation_count":23,"is_preprint":false},{"pmid":"15962313","id":"PMC_15962313","title":"Osteoblast calcium-sensing receptor has characteristics of ANF/7TM receptors.","date":"2005","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15962313","citation_count":23,"is_preprint":false},{"pmid":"1531129","id":"PMC_1531129","title":"Basal and volume expansion-stimulated plasma atrial natriuretic peptide concentrations and hemodynamics in conscious rats: effects of SCH 39.370, an endopeptidase inhibitor, and C-ANF-(4-23), a clearance receptor ligand.","date":"1992","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/1531129","citation_count":23,"is_preprint":false},{"pmid":"22296859","id":"PMC_22296859","title":"Characterization of a long-acting recombinant human serum albumin-atrial natriuretic factor (ANF) expressed in Pichia pastoris.","date":"2012","source":"Regulatory peptides","url":"https://pubmed.ncbi.nlm.nih.gov/22296859","citation_count":23,"is_preprint":false},{"pmid":"23465708","id":"PMC_23465708","title":"Identification of HESX1 mutations in Kallmann syndrome.","date":"2013","source":"Fertility and sterility","url":"https://pubmed.ncbi.nlm.nih.gov/23465708","citation_count":22,"is_preprint":false},{"pmid":"21635224","id":"PMC_21635224","title":"Ca2+-induced PARP-1 activation and ANF expression are coupled events in cardiomyocytes.","date":"2011","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/21635224","citation_count":22,"is_preprint":false},{"pmid":"25500790","id":"PMC_25500790","title":"Molecular analysis of PROP1, POU1F1, LHX3, and HESX1 in Turkish patients with combined pituitary hormone deficiency: a multicenter study.","date":"2014","source":"Endocrine","url":"https://pubmed.ncbi.nlm.nih.gov/25500790","citation_count":22,"is_preprint":false},{"pmid":"7840642","id":"PMC_7840642","title":"Catalytic activation of guanylate cyclase/atrial natriuretic factor receptor by combined effects of ANF and GTP gamma S in plasma membranes of Leydig tumor cells: involvement of G-proteins.","date":"1995","source":"Archives of biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/7840642","citation_count":22,"is_preprint":false},{"pmid":"2158751","id":"PMC_2158751","title":"Dehydration increases the density of C receptors for ANF on rat glomerular membranes.","date":"1990","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/2158751","citation_count":22,"is_preprint":false},{"pmid":"10626545","id":"PMC_10626545","title":"HESX1: a novel gene implicated in a familial form of septo-optic dysplasia.","date":"1999","source":"Acta paediatrica (Oslo, Norway : 1992). Supplement","url":"https://pubmed.ncbi.nlm.nih.gov/10626545","citation_count":21,"is_preprint":false},{"pmid":"16527264","id":"PMC_16527264","title":"Conserved regulatory elements establish the dynamic expression of Rpx/HesxI in early vertebrate development.","date":"2006","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/16527264","citation_count":21,"is_preprint":false},{"pmid":"1838022","id":"PMC_1838022","title":"Studies of ANF processing and secretion using a primary cardiocyte culture model.","date":"1991","source":"Canadian journal of physiology and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/1838022","citation_count":21,"is_preprint":false},{"pmid":"27000987","id":"PMC_27000987","title":"HESX1 mutations in patients with congenital hypopituitarism: variable phenotypes with the same genotype.","date":"2016","source":"Clinical endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/27000987","citation_count":21,"is_preprint":false},{"pmid":"7537466","id":"PMC_7537466","title":"ANF and angiotensin II interact via kinases in the proximal straight tubule.","date":"1995","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/7537466","citation_count":21,"is_preprint":false},{"pmid":"17931718","id":"PMC_17931718","title":"DNMT1 interacts with the developmental transcriptional repressor HESX1.","date":"2007","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/17931718","citation_count":20,"is_preprint":false},{"pmid":"1322053","id":"PMC_1322053","title":"ANF and bradykinin synergistically inhibit transport in M-1 cortical collecting duct cell line.","date":"1992","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/1322053","citation_count":20,"is_preprint":false},{"pmid":"8386616","id":"PMC_8386616","title":"Ascorbic acid enhances forskolin-induced cyclic AMP production and pro-ANF mRNA expression of hypothalamic neurons in culture.","date":"1993","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/8386616","citation_count":20,"is_preprint":false},{"pmid":"2953924","id":"PMC_2953924","title":"Comparative effect of ANF and various diuretics on isolated nephron segments.","date":"1987","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/2953924","citation_count":20,"is_preprint":false},{"pmid":"10843902","id":"PMC_10843902","title":"Sulfonylurea receptor ligands modulate stretch-induced ANF secretion in rat atrial myocyte culture.","date":"2000","source":"American journal of physiology. Heart and circulatory physiology","url":"https://pubmed.ncbi.nlm.nih.gov/10843902","citation_count":20,"is_preprint":false},{"pmid":"1852117","id":"PMC_1852117","title":"CGRP and ANF cause relaxation of opossum internal anal sphincter via different mechanisms.","date":"1991","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/1852117","citation_count":19,"is_preprint":false},{"pmid":"2159278","id":"PMC_2159278","title":"Photoaffinity labelling of atrial natriuretic factor (ANF)-R1 receptor by underivatized 125I-ANF. Involvement of lipid peroxidation.","date":"1990","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/2159278","citation_count":18,"is_preprint":false},{"pmid":"20949537","id":"PMC_20949537","title":"Candidate gene sequencing of LHX2, HESX1, and SOX2 in a large schizencephaly cohort.","date":"2010","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/20949537","citation_count":17,"is_preprint":false},{"pmid":"1838026","id":"PMC_1838026","title":"Developing essential hypertension: a syndrome involving ANF deficiency?","date":"1991","source":"Canadian journal of physiology and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/1838026","citation_count":16,"is_preprint":false},{"pmid":"1417928","id":"PMC_1417928","title":"The pharmacokinetics of 125I-atrial natriuretic factor in anaesthetized rats. Effects of neutral endopeptidase inhibition with candoxatrilat and of ANF-C receptor blockade.","date":"1992","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/1417928","citation_count":16,"is_preprint":false},{"pmid":"7918434","id":"PMC_7918434","title":"Functional characterization of ribozymes expressed using U1 and T7 vectors for the intracellular cleavage of ANF mRNA.","date":"1994","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7918434","citation_count":16,"is_preprint":false},{"pmid":"1838029","id":"PMC_1838029","title":"Neutral metalloendopeptidase inhibitors as ANF potentiators: sites and mechanisms of action.","date":"1991","source":"Canadian journal of physiology and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/1838029","citation_count":16,"is_preprint":false},{"pmid":"1838723","id":"PMC_1838723","title":"Proteinase activities in bovine atrium and the possible role of mast cell tryptase in the processing of atrial natriuretic factor (ANF).","date":"1991","source":"Comparative biochemistry and physiology. B, Comparative biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/1838723","citation_count":16,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":52296,"output_tokens":5302,"usd":0.118209,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":13653,"output_tokens":4057,"usd":0.084845,"stage2_stop_reason":"end_turn"},"total_usd":0.203054,"stage1_batch_id":"msgbatch_01DUPACZi7AAWwuZiUjseQF4","stage2_batch_id":"msgbatch_018yt7chE3f48PEFtDwtj6AE","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1998,\n      \"finding\": \"A homozygous Arg53Cys missense mutation within the HESX1 homeodomain destroyed its ability to bind target DNA, establishing that DNA binding by HESX1 is required for normal forebrain, midline, and pituitary development. Mouse knockouts lacking Hesx1 showed variable anterior CNS defects and pituitary dysplasia.\",\n      \"method\": \"Gel shift (EMSA) DNA-binding assay of mutant protein; targeted gene knockout in mice with phenotypic analysis\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — in vitro DNA-binding assay directly demonstrating loss of function, combined with knockout mouse phenotype; replicated across human and mouse\",\n      \"pmids\": [\"9620767\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Hesx1 (Rpx) is expressed as two transcripts encoding an identical 185-amino-acid homeodomain protein that defines a new homeodomain class (sharing 80% identity with Xenopus XANF-1). Expression is down-regulated during ES cell differentiation, consistent with a role in early developmental decisions.\",\n      \"method\": \"Molecular cloning, sequencing, Northern blot, and tissue-specific expression analysis from embryonic stem cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — biochemical characterization of a novel gene with sequence analysis and expression profiling; single lab, multiple methods\",\n      \"pmids\": [\"7876132\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"In the Ames dwarf (df) mouse, the df gene acts upstream of Pit1 in pituitary ontogeny: df mutants fail to extinguish Rpx/Hesx1 transcription by e13.5, and the pituitary is hypocellular, whereas Pit1-mutant pituitaries down-regulate Rpx normally. This genetic epistasis places Rpx repression as a prerequisite for lineage-specific cell proliferation.\",\n      \"method\": \"Genetic epistasis analysis in double-mutant mice (df and Pit1-dw); RNA in situ hybridization; pituitary cell-size measurements\",\n      \"journal\": \"Molecular endocrinology (Baltimore, Md.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — rigorous double-mutant epistasis with multiple orthogonal readouts (gene expression, cell proliferation), clearly ordering gene function\",\n      \"pmids\": [\"8961267\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Hesx1 is required cell-autonomously within the anterior neural ectoderm (ANE) for normal forebrain formation. Chimeric analysis showed that Hesx1-deficient visceral endoderm does not cause forebrain defects, but Hesx1-null cells in the ANE do. Downstream ANE markers Six3 and Rax/Rx are normally expressed until the early somite stage but become markedly reduced ~24 h after Hesx1 is first expressed in the ANE.\",\n      \"method\": \"Chimeric embryo analysis (ES cell injection into wild-type blastocysts and reciprocal); RNA in situ hybridization for tissue markers\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal chimeric rescue experiments combined with marker in situ hybridization, rigorously establishing cell-autonomous ANE requirement\",\n      \"pmids\": [\"10882526\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"HESX1 is a promoter-specific transcriptional repressor with a minimal 36-amino-acid repression domain. It suppresses homeodomain-containing activator proteins. Wild-type HESX1 binds a dimeric homeodomain site with high affinity (Kd ~31 nM); HESX1-S170L binds with ~5-fold lower affinity (Kd ~150 nM); HESX1-R160C does not bind DNA at all. HESX1-R160C also acts as a dominant negative by inhibiting wild-type HESX1 DNA binding both in vitro and in cell culture, via its repression domain.\",\n      \"method\": \"Electrophoretic mobility shift assay (EMSA) with purified proteins; luciferase reporter transcription assays in cell culture; deletion mutagenesis defining the repression domain\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — quantitative in vitro binding assays with mutagenesis, complemented by cell-based reporter assays; multiple orthogonal methods in a single rigorous study\",\n      \"pmids\": [\"11748154\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Gel shift analysis of the HESX1-S170L mutant protein showed a significant reduction in relative DNA-binding activity, linking this heterozygous mutation to sporadic pituitary hypoplasia.\",\n      \"method\": \"Gel shift (EMSA) assay of mutant HESX1 protein\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — direct in vitro DNA-binding assay, but single method in a single lab\",\n      \"pmids\": [\"11136712\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"A homozygous I26T mutation in the Engrailed homology 1 (eh1) repressor domain of HESX1 does not affect DNA binding but abolishes recruitment of the Groucho homologue/TLE1 corepressor, leading to partial loss of transcriptional repression. This demonstrates that the eh1 domain is required for HESX1–TLE1 interaction and full repressor activity.\",\n      \"method\": \"In vitro binding assays (co-immunoprecipitation of HESX1 and TLE1); transcriptional repression assays in cell culture with wild-type and I26T mutant HESX1; EMSA for DNA binding\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — multiple orthogonal methods (CoIP, reporter assay, EMSA) in a single study dissecting distinct functional domains; single lab\",\n      \"pmids\": [\"14561704\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"A novel HESX1 mutation (g.1684delG) generates a mutant protein with increased DNA-binding activity, causing enhanced repression of PROP1-dependent gene activity. This demonstrates that gain-of-repressor function is a mechanism for congenital pituitary disorders, distinct from previously described loss-of-function mutations.\",\n      \"method\": \"Luciferase reporter transcriptional repression assays; EMSA DNA-binding assays with mutant HESX1 protein\",\n      \"journal\": \"The Journal of clinical endocrinology and metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — reporter and EMSA assays demonstrating gain-of-function; single lab with two orthogonal methods\",\n      \"pmids\": [\"14557462\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Two novel homozygous HESX1 mutations (a frameshift c.449_450delAC and a splice defect c.357+2T>C) produce truncated proteins lacking part or all of the homeodomain, with complete loss of transcriptional repressor activity as demonstrated by inability to inhibit PROP1 activity in reporter assays.\",\n      \"method\": \"Sequencing of HESX1 exons; RT-PCR analysis of transcripts from splice mutant; luciferase-based transcriptional repression assay\",\n      \"journal\": \"The Journal of clinical endocrinology and metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — functional reporter assay combined with transcript analysis; single lab\",\n      \"pmids\": [\"16940453\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Hesx1 functions as an essential repressor in the anterior forebrain; its absence leads to a posterior transformation of the anterior forebrain via ectopic activation of Wnt/β-catenin signalling within the Hesx1 expression domain. Conditional deletion of β-catenin in the anterior forebrain of Hesx1-deficient embryos significantly rescues the forebrain defects.\",\n      \"method\": \"Genetic cell labelling; marker gene analysis; conditional knockout of β-catenin in Hesx1-null background (double mutant rescue); transcriptional profiling of anterior forebrain precursors\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional double-mutant rescue with multiple orthogonal methods; pathway placement via genetic epistasis\",\n      \"pmids\": [\"17360769\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"DNMT1 (DNA methyltransferase 1) is a binding partner of HESX1. The entire HESX1 protein is required for binding to the N-terminus and catalytic C-terminal domain of DNMT1. HESX1–DNMT1 complexes co-immunoprecipitate in cells and co-localise in the nucleus; Dnmt1 and Hesx1 are co-expressed in anterior forebrain and Rathke's pouch.\",\n      \"method\": \"Yeast two-hybrid screen; co-immunoprecipitation; deletion-mutant binding mapping; co-localisation by immunofluorescence in cells\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — yeast two-hybrid plus reciprocal co-IP plus co-localisation; single lab\",\n      \"pmids\": [\"17931718\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Knock-in mice carrying the I26T substitution in Hesx1 show pituitary defects comparable to Hesx1-null mice, confirming I26T as a hypomorphic allele. Knock-in mice carrying R160C show full forebrain and pituitary defects identical to null mice, confirming R160C is a null allele. HESX1 expression during early human development mirrors the mouse, supporting conservation of function.\",\n      \"method\": \"Generation of two Hesx1 knock-in mouse lines (I26T and R160C) by gene targeting; histological and molecular phenotypic analysis; immunohistochemistry in human embryos\",\n      \"journal\": \"Disease models & mechanisms\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — two independent knock-in models with rigorous phenotypic characterisation establish allelic series\",\n      \"pmids\": [\"19093031\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Hesx1 interacts genetically with Six3 during pituitary development: Six3+/-;Hesx1Cre/+ compound heterozygous mice display severe pituitary hypoplasia with an expanded/bifurcated Rathke's pouch due to increased cell proliferation, revealing a genetic interaction between Hesx1 and Six3 in controlling pituitary organogenesis.\",\n      \"method\": \"Generation of Six3+/-;Hesx1Cre/+ double-heterozygous mice; histological and proliferation analyses; endocrine phenotype assessment\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean genetic epistasis in vivo with multiple tissue readouts; single lab\",\n      \"pmids\": [\"18775421\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"The Xenopus/Hesx1 ortholog Xanf1 binds the LIM-domain protein Zyxin through its Engrailed-type repressor domain (eh1), and Zyxin LIM2 domain is required for the interaction. Zyxin overexpression mimics Xanf1 knockdown, while a repressor-fused Zyxin mimics Xanf1 overexpression, indicating Zyxin acts as a negative modulator of Xanf1 transcriptional repressing activity in the anterior neural plate.\",\n      \"method\": \"Deletion-mutant pulldown mapping; Xenopus embryo overexpression and morpholino knockdown with phenotypic readout\",\n      \"journal\": \"Developmental dynamics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — binding domain mapping combined with in vivo gain/loss-of-function; single lab\",\n      \"pmids\": [\"18297730\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"HESX1 interacts with both TLE1 and TLE3 corepressors to repress PROP1-dependent transcription. TLE3 had not previously been shown to interact with HESX1. In transgenic mice, HESX1 alone (but not TLE3 alone) suppresses terminal differentiation of thyrotrophs and gonadotrophs when constitutively expressed, and TLE3 together with HESX1 shows similar suppression, demonstrating that TLE corepressors augment HESX1-mediated repression.\",\n      \"method\": \"Cell-based luciferase reporter assays; co-immunoprecipitation; transgenic mouse overexpression in pituitary thyrotrophs/gonadotrophs with cell differentiation readout\",\n      \"journal\": \"Molecular endocrinology (Baltimore, Md.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal CoIP, reporter assays, and transgenic in vivo validation; multiple orthogonal methods\",\n      \"pmids\": [\"20181723\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"HESX1 and TCF3 (a transcriptional repressor of Wnt target genes) act synergistically to maintain anterior forebrain identity by repressing Wnt/β-catenin targets. Hesx1/Tcf3 double-heterozygous mice show severe forebrain defects not seen in single heterozygotes. Morpholino knockdown of hesx1 in tcf3-mutant zebrafish causes severe forebrain and eye defects. Tcf3 conditional knockout in the neural ectoderm causes anterior forebrain loss, and Tcf3/Hesx1 compound deficiency amplifies this. Transcriptional profiling of Hesx1-expressing forebrain precursors provides molecular evidence for Wnt target repression.\",\n      \"method\": \"Double-mutant mouse epistasis; zebrafish morpholino knockdown in sensitised tcf3 mutant background; conditional knockout; transcriptional profiling (gene expression array)\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple species (mouse, zebrafish), conditional and compound knockouts, transcriptional profiling; independently convergent methods\",\n      \"pmids\": [\"22007134\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"The HESX1/ANF homeobox gene promoter is directly activated by Otx2 through two conserved Otx2-binding sites in a ~1-kb upstream enhancer, as shown by in vivo mutagenesis in chick and zebrafish transgenic embryos. Additionally, Pax6 occupies a binding site near the transcriptional start site in vivo and inhibits GANF/Hesx1 expression: Pax6 overexpression represses endogenous GANF, and in Pax6-null mice the Hesx1 expression domain is expanded and prolonged.\",\n      \"method\": \"In vivo site mutagenesis in transgenic chick and zebrafish; chromatin/in vivo occupancy analysis; Pax6-null mouse marker analysis; overexpression experiments\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo mutagenesis plus loss-of-function in Pax6 knockout; single lab with multiple complementary approaches\",\n      \"pmids\": [\"15110720\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Conserved 5′ upstream regulatory sequences of Rpx/Hesx1 contain two LIM protein-binding sites that are required for Rpx promoter activity and are directly bound by LIM homeodomain proteins Lhx1 and Lhx3, which regulate early Rpx transcription in the anterior endoderm and neural plate. A conserved 3′ enhancer is necessary and sufficient for Rpx expression in Rathke's pouch.\",\n      \"method\": \"Transgenic mouse reporter analysis with deletion constructs; electrophoretic mobility shift assay (EMSA) for Lhx1 and Lhx3 binding; Xenopus transgenic assay\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — EMSA plus in vivo transgenic reporter mutagenesis; single lab with two species\",\n      \"pmids\": [\"16527264\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Wild-type OTX2 protein binds to the HESX1 promoter and transactivates it ~4.5-fold. A frameshift OTX2 mutation that retains the homeodomain but loses the transactivation domain fails to transactivate the HESX1 promoter, establishing HESX1 as a direct transcriptional target of OTX2 in the pituitary context.\",\n      \"method\": \"Luciferase reporter assay with wild-type and mutant OTX2; nuclear localisation confirmed by imaging\",\n      \"journal\": \"The Journal of clinical endocrinology and metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — reporter assay is direct, but single lab, single method for the HESX1 promoter specifically\",\n      \"pmids\": [\"18628516\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Compound heterozygous HESX1 mutations p.R159W and p.R160H each abrogate the ability of HESX1 to repress PROP1-mediated transcriptional activation, demonstrating that both residues are required for HESX1 repressor function toward PROP1.\",\n      \"method\": \"Luciferase reporter transcriptional repression assay with mutant HESX1 proteins\",\n      \"journal\": \"Clinical endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Weak — direct functional reporter assay, single lab, single method\",\n      \"pmids\": [\"27000987\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"HESX1 is a homeodomain transcriptional repressor that is expressed sequentially in the anterior visceral endoderm, anterior axial mesendoderm, and anterior neural ectoderm during early development, where it is required cell-autonomously for forebrain patterning by repressing Wnt/β-catenin target genes (in concert with TCF3) and for Rathke's pouch morphogenesis; it represses target promoters through a 36-amino-acid Engrailed-homology (eh1) domain that recruits the Groucho-related corepressors TLE1 and TLE3, and through its homeodomain that binds dimeric homeodomain sites with high affinity to antagonize PROP1-mediated activation; its transcription is activated by Otx2 and LIM-homeodomain proteins (Lhx1, Lhx3) and repressed by Pax6, while it can also interact with DNMT1 and Zyxin, broadening the repertoire of mechanisms through which it enforces anterior neural identity.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"HESX1 is a homeodomain transcriptional repressor that enforces anterior neural identity and pituitary organogenesis during early development, where it is required cell-autonomously within the anterior neural ectoderm for forebrain formation [#3, #9]. It binds dimeric homeodomain DNA sites with high affinity through its homeodomain, and mutations that abolish or weaken this binding (R160C, S170L) cause forebrain, midline, and pituitary defects; R160C additionally acts as a dominant negative by sequestering wild-type protein [#0, #4, #5, #11]. Repression is executed through a 36-amino-acid Engrailed-homology (eh1) domain that recruits the Groucho-related corepressors TLE1 and TLE3, and an eh1 point mutation (I26T) abolishes TLE1 recruitment and produces a hypomorphic allele in vivo [#6, #11, #14]. In the forebrain, HESX1 antagonizes Wnt/\\u03b2-catenin signalling to prevent posterior transformation of anterior tissue, acting synergistically with the Wnt repressor TCF3, and conditional removal of \\u03b2-catenin rescues the Hesx1-null forebrain [#9, #15]. In the pituitary it antagonizes PROP1-mediated activation, and its own expression must be extinguished to permit lineage-specific proliferation, as shown by genetic epistasis with the Ames dwarf locus and Six3 [#2, #12, #19]. HESX1 transcription is directly activated by OTX2 and by the LIM-homeodomain proteins Lhx1 and Lhx3, and repressed by Pax6 [#16, #17, #18]. It also physically interacts with DNMT1 and, via its ortholog Xanf1, with Zyxin, extending the repertoire of its repressive mechanisms [#10, #13].\",\n  \"teleology\": [\n    {\n      \"year\": 1995,\n      \"claim\": \"Established HESX1/Rpx as a novel-class homeodomain protein whose expression marks early developmental decisions, defining the molecule before its function was known.\",\n      \"evidence\": \"Molecular cloning, sequencing, and expression profiling in differentiating ES cells\",\n      \"pmids\": [\"7876132\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No functional or phenotypic data\", \"DNA-binding specificity not yet defined\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Placed Rpx/Hesx1 repression upstream of Pit1 in pituitary ontogeny, showing that its extinction is a prerequisite for lineage-specific proliferation.\",\n      \"evidence\": \"Double-mutant epistasis (Ames df and Pit1-dw mice) with in situ hybridization and cell-size measurement\",\n      \"pmids\": [\"8961267\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular identity of the df gene unresolved here\", \"Direct transcriptional targets not identified\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Demonstrated that DNA binding by HESX1 is required for forebrain, midline, and pituitary development by linking a homeodomain missense mutation that abolishes binding to disease and recapitulating defects in knockout mice.\",\n      \"evidence\": \"EMSA of mutant protein plus targeted knockout in mice with phenotypic analysis\",\n      \"pmids\": [\"9620767\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Target genes bound in vivo not defined\", \"Repression mechanism not yet established\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Resolved the tissue of action, showing HESX1 is required cell-autonomously in the anterior neural ectoderm rather than visceral endoderm for forebrain formation.\",\n      \"evidence\": \"Reciprocal chimeric embryo analysis with marker in situ hybridization (Six3, Rax)\",\n      \"pmids\": [\"10882526\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct vs indirect regulation of Six3/Rax not distinguished\", \"Signalling pathway antagonized not identified\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Defined HESX1 as a promoter-specific repressor with a minimal 36-residue repression domain and quantified how disease mutations alter DNA binding, including a dominant-negative mechanism.\",\n      \"evidence\": \"Quantitative EMSA with purified proteins, luciferase reporter assays, deletion mutagenesis (with allele-specific EMSA in a parallel study)\",\n      \"pmids\": [\"11748154\", \"11136712\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Corepressor recruited by the repression domain not yet identified\", \"Physiological target promoters unknown\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Identified the eh1 domain as the corepressor-recruitment module by showing an I26T mutation preserves DNA binding but abolishes TLE1/Groucho recruitment, and documented a gain-of-repressor mechanism for pituitary disease.\",\n      \"evidence\": \"Co-IP of HESX1 and TLE1, reporter repression assays, and EMSA; separate reporter/EMSA study of a frameshift gain-of-function allele\",\n      \"pmids\": [\"14561704\", \"14557462\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether TLE recruitment occurs at endogenous promoters not shown\", \"In vivo consequence of I26T not yet tested at this stage\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Connected HESX1 to its upstream regulatory network by showing Otx2 directly activates and Pax6 directly represses the promoter.\",\n      \"evidence\": \"In vivo site mutagenesis in transgenic chick/zebrafish, occupancy analysis, and Pax6-null marker analysis\",\n      \"pmids\": [\"15110720\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Combinatorial logic of activators and repressors not resolved\", \"Single lab\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Extended the upstream network by mapping distinct enhancers and showing LIM-homeodomain proteins Lhx1 and Lhx3 directly bind and drive early Rpx transcription.\",\n      \"evidence\": \"Transgenic reporter deletion analysis and EMSA in mouse and Xenopus\",\n      \"pmids\": [\"16527264\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional requirement of Lhx binding in vivo not tested by knockout\", \"3' Rathke's pouch enhancer regulators not identified\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Established the core developmental mechanism: HESX1 represses Wnt/\\u03b2-catenin signalling to prevent posterior transformation of anterior forebrain, and identified DNMT1 as a physical partner.\",\n      \"evidence\": \"Conditional \\u03b2-catenin deletion in Hesx1-null background (rescue) with profiling; yeast two-hybrid, co-IP, and co-localization for DNMT1\",\n      \"pmids\": [\"17360769\", \"17931718\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct Wnt target promoters bound by HESX1 not enumerated\", \"Functional consequence of DNMT1 interaction not demonstrated\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Validated the allelic series in vivo (I26T hypomorph, R160C null), revealed genetic interaction with Six3 in pituitary proliferation, identified Zyxin as a negative modulator of the ortholog, and confirmed OTX2 directly transactivates the HESX1 promoter.\",\n      \"evidence\": \"Two knock-in mouse lines; Six3;Hesx1 compound heterozygote analysis; Xenopus Xanf1\\u2013Zyxin pulldown and gain/loss-of-function; OTX2 reporter assay\",\n      \"pmids\": [\"19093031\", \"18775421\", \"18297730\", \"18628516\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which Six3 dosage controls pouch proliferation unresolved\", \"Zyxin modulation shown only in Xenopus ortholog\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Broadened the corepressor mechanism by showing HESX1 recruits both TLE1 and TLE3 to repress PROP1-dependent transcription, with TLE corepressors augmenting repression in vivo.\",\n      \"evidence\": \"Reciprocal co-IP, reporter assays, and transgenic pituitary overexpression with differentiation readout\",\n      \"pmids\": [\"20181723\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Endogenous PROP1 target genes co-repressed not mapped\", \"Relative contribution of TLE1 vs TLE3 in vivo unclear\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Demonstrated that HESX1 and TCF3 act synergistically to repress Wnt targets and maintain anterior forebrain identity across species.\",\n      \"evidence\": \"Double-mutant mouse epistasis, zebrafish morpholino knockdown in tcf3 background, conditional knockout, and transcriptional profiling\",\n      \"pmids\": [\"22007134\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether HESX1 and TCF3 co-occupy shared promoters not shown directly\", \"Specific Wnt target genes repressed not fully enumerated\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Confirmed that conserved homeodomain residues R159 and R160 are individually required for repression of PROP1, refining genotype-phenotype relationships.\",\n      \"evidence\": \"Luciferase reporter repression assay with compound-heterozygous mutant proteins\",\n      \"pmids\": [\"27000987\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"DNA-binding consequences of these residues not assayed here\", \"Single method, single lab\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The genome-wide direct target repertoire of HESX1 and how its DNMT1 interaction contributes to repression at endogenous loci remain undefined.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No ChIP-based genome-wide occupancy map\", \"Functional role of HESX1\\u2013DNMT1 in DNA methylation untested\", \"Structural model of the homeodomain on dimeric sites lacking\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 4, 5, 7]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [4, 6, 14, 15]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [6, 14]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [10]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [4, 6, 14]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [3, 9, 12, 15]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [9, 15]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"TLE1\", \"TLE3\", \"PROP1\", \"TCF3\", \"DNMT1\", \"OTX2\", \"LHX1\", \"LHX3\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}